Search
-
As Director of Library Services for the Memorial Sloan Kettering Cancer Center Library, Donna Gibson is focused on delivering services that enhance the user’s information retrieval experience from start to finish.
… Job Title Director, Library Services As Director of Library Services for the Memorial Sloan Kettering Cancer Center Library , I am focused on delivering services that enhance the user’s information retrieval experience from start to finish. This includes partnering with users to better understand how
-
-
News
The final survival analysis of an international study of a new drug for prostate cancer has found an even greater median survival benefit than previously reported, and has established a new class of treatment for men with metastatic prostate cancer. In addition, researchers are exploring a potential biomarker of response to treatment in general.
… Saturday, June 4, 2011 The final survival analysis of an international study of a new drug for prostate cancer has found an even greater median survival benefit than previously reported, and has established a new class of treatment for men with metastatic prostate cancer. In addition, researchers are
-
The Agnel Sfeir Lab
… Job Title BCMB Student Education BSc, Andrews University (2013) Email [email protected]
-
News
Researchers at the Sloan Kettering Institute have found that changes in an information-carrying molecule called messenger RNA (mRNA) can inactivate the functions of tumor suppressor genes and thereby promote cancer. The findings pinpoint previously unknown drivers of the disease, indicating that cancer diagnostics need to go beyond the analysis of DNA mutations.
… Monday, August 27, 2018 Bottom Line: Researchers at the Sloan Kettering Institute have found that changes in an information-carrying molecule called messenger RNA (mRNA) can inactivate the functions of tumor suppressor genes and thereby promote cancer. The findings pinpoint previously unknown drivers
-
Technology Development
This MSK technology is a cancer-testis antigen with restricted expression in normal tissues but broad overexpression across multiple cancer types, making it an ideal target for cancer immunotherapy.
… SK2021-008 SUMMARY OF INVENTION Preferentially Expressed Antigen in Melanoma (PRAME) represents an ideal target for cancer immunotherapy as a cancer-testis antigen with restricted expression in normal tissues but broad overexpression across multiple cancer types. MSK investigators have developed a T-cell
-
Genomics, Risk, and Health Decision-Making Laboratory
… Rebecca Gebert is currently a Clinical Research Coordinator in the MSK Department of Psychiatry and Behavioral Sciences. She recently graduated with her BA in Psychology from the Honors Program at Iona College. Her research interests include the impacts of social media use on adolescents and young adults
-
The Joan Massagué Lab
… Job Title Group Leader, Institut de Recerca Biomedica, Barcelona Education University of Barcelona Degree PhD Start Year 2003 End Year 2006 Email [email protected]
-
Video
Memorial Sloan Kettering family nurse practitioner Carol Ann Milazzo describes side effects commonly caused by palliative radiation therapy to the brain.
… Memorial Sloan Kettering nurse practitioner Carol Ann Milazzo describes side effects commonly associated with radiation therapy to the brain. Radiation can cause patients to feel temporarily fatigued. Other common temporary side effects may include hair loss, headaches, nausea, and short-term memory
-
The James Fagin Lab
… Job Title Visiting Investigator Email [email protected]